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Background: The fungal cell wall forms a compact network whose integrity is essential for cell morphology and viability.
Thus, fungal cells have evolved mechanisms to elicit adequate adaptive responses when cell wall integrity (CWI) is
compromised. Functional genomic approaches provide a unique opportunity to globally characterize these adaptive
mechanisms. To provide a global perspective on these CWI regulatory mechanisms, we developed chemical-genomic
profiling of haploid mutant budding yeast cells to systematically identify in parallel those genes required to cope with
stresses interfering the cell wall by different modes of action: β-1,3 glucanase and chitinase activities (zymolyase),
inhibition of β-1,3 glucan synthase (caspofungin) and binding to chitin (Congo red).
Results: Measurement of the relative fitness of the whole collection of 4786 haploid budding yeast knock-out mutants
identified 222 mutants hypersensitive to caspofungin, 154 mutants hypersensitive to zymolyase, and 446 mutants
hypersensitive to Congo red. Functional profiling uncovered both common and specific requirements to cope with
different cell wall damages. We identified a cluster of 43 genes highly important for the integrity of the cell wall as the
common “signature of cell wall maintenance (CWM)”. This cluster was enriched in genes related to vesicular trafficking
and transport, cell wall remodeling and morphogenesis, transcription and chromatin remodeling, signal transduction and
RNA metabolism. Although the CWI pathway is the main MAPK pathway regulating cell wall integrity, the collaboration
with other signal transduction pathways like the HOG pathway and the invasive growth pathway is also required
to cope with the cell wall damage depending on the nature of the stress. Finally, 25 mutant strains showed enhanced
caspofungin resistance, including 13 that had not been previously identified. Only three of them, wsc1Δ, elo2Δ and
elo3Δ, showed a significant decrease in β-1,3-glucan synthase activity.
Conclusions: This work provides a global perspective about the mechanisms involved in cell wall stress adaptive
responses and the cellular functions required for cell wall integrity. The results may be useful to uncover new potential
antifungal targets and develop efficient antifungal strategies by combination of two drugs, one targeting the cell wall
and the other interfering with the adaptive mechanisms.
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The main physical barrier to protect fungal cells from
osmotic shock and other challenging environmental con-
ditions is constituted by the cell wall. The cell wall of
the budding yeast Saccharomyces cerevisiae is formed by
an inner layer containing β-1,3 glucan, β-1,6 glucan and
chitin, and an outer layer composed of mannoproteins
[1]. All these components are linked to each other to
form a compact network whose integrity is essential for
cell morphology and viability [2, 3]. Since the cell wall
is essential for fungal survival and its composition is
unique, this structure is an excellent target for anti-
fungal drugs [4, 5]. In fact, several agents interfering
with the synthesis of β-1,3 glucan and chitin have been
developed. A good example is the echinocandin family
of β-1,3 glucan synthase (GS) non-competitive inhibi-
tors which includes micafungin, anidulafungin and
caspofungin (CAS) [5, 6].
To ensure their integrity, fungal cells have evolved mech-
anisms to detect cell wall damage and elicit adequate adap-
tive responses. The major signaling pathway regulating
these mechanisms is the Slt2/Mpk1 mitogen-activated
protein kinase (MAPK) cell wall integrity (CWI) pathway,
which is activated by conditions that compromise cell wall
integrity such as chemical cell wall-perturbing agents or
mutations that impair cell wall stability [7–9]. The final
consequence of the activation of this pathway is the induc-
tion of an adaptive transcriptional program extensively
studied by genome-wide expression profiling, that ultim-
ately causes the remodeling of cell wall architecture for
survival [10–14]. This adaptive compensatory response,
which is also triggered by echinocandin-derivate antifun-
gals, creates a new potential concept in antifungal drug
treatment based on the possibility of combinatorial therapy
using two drugs together, one targeting the cell wall and
the other targeting the molecular mechanism of fungal
adaptive response [15, 16].
Functional genomic approaches using the model
organism S. cerevisiae provide a unique opportunity to
globally study these adaptive mechanisms through the
characterization of mutant collections [17], genome-
wide gene expression profiling [18] and genetic interac-
tions [19]. Genome-wide transcriptional profiles to dif-
ferent types of cell wall stress have shown the existence
of a common transcriptional adaptive response but also
the existence of specific gene expression effects for
each situation [20]. Although the CWI pathway is cru-
cial in the regulation of yeast adaptive responses against
cell wall damage, other pathways are also involved.
Thus, whereas transcriptional adaptive responses to the
presence of Congo red (CR) almost completely depends
on the transcriptional factor Rlm1 and the MAPK Slt2
[13], activation of CWI signaling in response to treatment
with zymolyase (ZYM), an enzymatic cocktail containingβ-1,3 glucanase, protease, mannanase and chitinase activ-
ities, requires a sequential activation by this stress of the
two CWI and high osmolarity glycerol (HOG) pathways
[14, 21]. Additionally, β-1,3 glucan inhibitors induce tran-
scriptional responses only partially dependent on Rlm1
(García, R., Bravo, E., Rodriguez-Peña, JM and Arroyo, J,
unpublished results), suggesting the participation of add-
itional signaling pathways. Genome-wide surveys of genes
regulated through the CWI pathway are also consistent
with the co-activation of CWI signaling and Ca2+ signaling
(Calcineurin/Crz1 pathway) as well as with general stress
signaling [12, 13, 22].
Chemical-genomic profiling of bioactive compounds
has been shown as a powerful approach for drug target
identification and mode of action studies [23, 24]. Previ-
ous published results have addressed the identification
of genes involved in cell wall biogenesis by means of
individually screening mutant collections for sensitivity
to calcofluor white [25, 26], K1 killer toxin [27] and
CAS [28, 29]. More recently, a genome-wide survey of
yeast mutations leading to the activation of the CWI
pathway has been conducted [9]. Here, to gain further
insight into CWI regulatory mechanisms and provide a
global perspective on the mechanisms involved in the cel-
lular adaptive responses to cell wall damage, we screened
in parallel the budding yeast collection of haploid mutant
strains to quantitatively measure the relative fitness of
each mutant to treatments with three different cell wall
perturbing agents: CR, ZYM and CAS. Our aim was to
systematically identify the genes required to cope with
stresses interfering the cell wall by different modes of
action, thus leading to well-characterized cell wall adaptive
transcriptional responses. This approach has allowed us to
obtain a comprehensive view of the gene network related
to cell wall homeostasis. Moreover, the comparative ana-
lysis of the genes required to tolerate the three agents under
study along with those from other conditions publicly avail-
able that potentially affect fungal cell integrity, has allowed
us to define a cell wall maintenance (CWM) gene signature
which includes those genes necessary to resist the majority
of situations in which cell wall is damaged. In addition, the
characterization of the set of mutants resistant to CAS and
CR revealed the significance of membrane lipids for the ac-
tivity of these compounds. Therefore, this work provides a
global perspective on the mechanisms involved in cell stress
adaptive responses and the cellular functions required for
cell wall integrity, which may be useful to uncover new
potential antifungal targets.
Results and discussion
Chemical-genomic profiling of Congo red, zymolyase and
caspofungin
To comprehensively characterize the cellular impact of
the cell wall interfering compounds CR, ZYM, and CAS,
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essential haploid deletion mutants. These compounds
were selected because they act on the cell wall by dif-
ferent stress mechanisms. CR binds to chitin interfering
with proper cell wall assembly [30, 31], whereas ZYM
affects cell wall integrity due to a main β-1,3 glucanase
activity and noticeable protease, mannanase and chiti-
nase activities [32–34]. Finally, echinocandins, includ-
ing CAS, interfere with the β-1,3 glucan network by
specifically inhibiting β-1,3 GS [35]. In agreement with
their different modes of action, the transcriptional
adaptive response to the three cell wall insults includes
common and specific transcripts and depends on differ-
ent cell surface sensors [36].
We first set up the optimal growth parameters for
each condition to identify hypersensitive yeast deletion
mutants relative to the wild-type strain. To obtain quan-
titative data about the growth levels, the screenings with
ZYM and CAS were performed in rich liquid medium
(YEPD) using a microtiter plate format and monitoring
the growth of each strain by measuring the absorbance
at 595 nm at different time points. In the case of Congo
red, we used a spot dilution assay on YEPD solid media.
Key parameters to be defined were the optimal drug
concentration and the growth conditions to be used.
Pilot assays, in which we measured the growth of the
wild type strain in the presence of different concentra-
tions of each compound, were designed to determine the
higher drug concentration that did not significantly
affect the growth of the wild type strain, named as
sub-MIC (minimal inhibitory concentration) (Additional
file 1). Additionally, some reference strains related to cell
wall stress response and known to be hypersensitive to
the compounds were also included, like the mutant in
the MAPK of the CWI pathway (slt2Δ) [13, 14, 28]. On
the basis of these results, we finally selected sub-MIC
doses of 30 U/ml ZYM and 50 μg/ml CR. In the case of
CAS, the range of hypersensitivity between the wild type
and slt2Δ strains was narrower (Additional file 1).
Therefore, we decided to include three sub-MIC doses
(10 ng/ml, 20 ng/ml and 30 ng/ml) in this screening. All
these concentrations do not affect the growth of the wild-
type strain but clearly inhibit the growth of the reference
hypersensitive strains.
Next, we quantitatively measured, for each compound-
dose, the relative fitness of the whole collection of 4786
haploid yeast knock-out mutants. After removing those
mutants that showed reduced growth in YEPD medium
in the absence of stress (slow-growth phenotype) to
avoid misinterpretation of the hypersensitivity levels, we
proceeded to confirm the positive hits in a second round
of phenotypic analysis. For CAS, the original screening
protocol was repeated confirming that all mutant strains
formerly detected showed hypersensitivity except five ofthem. For secondary screening of zymolyase hypersensi-
tive strains, we determined their MICs to zymolyase (see
Methods for details), confirming about 90 % of positive
hits. In the case of Congo red because the high number
of mutants selected (446 strains), we retested 13 % of
them (58 strains), corroborating the sensitivity to CR in
about 93 % of the strains. Eventually, we identified 222
mutants sensitive to CAS, 154 mutants sensitive to
ZYM, and 446 mutants sensitive to CR (Fig. 1a). Mu-
tants were arbitrarily ascribed to three categories (1–3)
based on their sensitivity level (low, medium and high,
respectively) as described in Methods. The complete
dataset of the 636 yeast mutants identified in our gen-
omic profiles including information about their degree
of growth alteration is described in Additional file 2.
Two previous genome-wide phenotypic analyses using
CAS have been published [28, 29]. However, probably
due to differences in the experimental methodology, drug
batch and drug concentrations used, we have identified a
significantly higher number of CAS sensitive strains. Lesage
and colleagues identified 52 CAS-sensitive strains, of which
34 (68 %) are common with our CAS-sensitive gene set,
whereas Markovich et al. identified 20 sensitive strains, of
which 17 (90 %) are coincident with our set.
To determine those enriched functional categories
represented within the 636 candidate hits, we used the
Gene Ontology (GO) tool “GO Term Finder”. A signifi-
cant enrichment for GO biological process terms related
to cell wall biogenesis, morphogenesis, stress and signal
transduction, but also to vesicle transport, transcription,
ion homeostasis, and cell cycle (Fig. 1b) was found, sug-
gesting that all these cellular processes are likely to be
important to cope with cell wall stress. For a complete
functional cataloging of the identified mutants, we used
the GO tool “GO Slim Mapper”, further refining the
search with annotations of the BIOBASE Knowledge
Library Proteome and the Saccharomyces Genome
Database (SGD) (Additional file 2).
Genome-wide functional profiling uncovers common and
specific requirements to cope with different cell wall
damages
Comparing the mutant strains identified in the three
screenings, a limited number of strains displayed overlap-
ing fitness profiles with at least two compounds, including
75, 91, and 48 mutants common to CR-ZYM, CR-CAS,
and ZYM-CAS treatments, respectively (Fig. 1a). More-
over, a core of 28 strains were hypersensitive to treatment
with the three compounds tested (Table 1). The set of
genes within this group must be essential to withstand cell
wall damages of different origin and includes essential
functions required to tolerate cell wall stress independ-
ently of the nature of the damage. This core of genes,
further described below, is enriched in general functions
Fig. 1 Global analysis of hypersensitive phenotypes to Congo red,
caspofungin and zymolyase. a Venn diagram summarizing the
distribution of yeast deletion mutants hypersensitive to the cell wall
interfering compounds. b Functional classification of genes identified
in the three genome-wide screenings according to the Gene Ontology
term finder tool (p-value <0.01). Only the statistically significant
functional groups identified are shown. p-values between 0.010-0.025
are labeled with an asterisk
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lated to V-ATPase activity), cell wall and morphogenesis,
transcription and chromatin remodelling, and signal trans-
duction (Table 1). This group also contains some genes that
function in multidrug resistance (MDR) response [37–39].
Despite the fact that there was a low number of overlaping
genes affecting cell fitness in the three conditions under
study (28 out of 636 detected in at least one condition), the
proportion of mutant strains affected in specific cellular
functions was similar for each chemical-genomic profile
(Fig. 1b). Thus, although several molecular processesare common to CR, CAS and ZYM adaptive responses,
specific gene/proteins are required to cope with distinct
cell wall alterations, showing the complexity and versa-
tility of the cellular cell wall stress response network.
An aspect to remark is the high number of strains
(308) that only showed a growth defect in the presence
of CR, in contrast to the effect observed for CAS (111)
and ZYM (59), suggesting that CR exerts a broader cell
wall injury.
Cell wall and morphogenesis related genes
Taken together, cell wall and morphogenesis categor-
ies included about 30 % of the hypersensitive mu-
tants identified in our chemical-genomic screenings.
For CAS, in addition to the prototypical cell wall
hypersensitive fks1Δ mutant (FKS1 encodes a cata-
lytic subunit of β-1,3 GS), mutants deleted in genes
involved in chitin synthesis such as CHS3 and SKT5
(directly related to chitin synthase III activity), CHS5,
CHS6 and CHS7 (involved in Chs3 export) and BNI4
(required for chitin synthase III localization) were
also identified. The level of cell growth inhibition in-
duced by CAS of these chitin-related mutants was
very similar, reinforcing the idea that the chitin gen-
erated by CSIII (chitin synthase III activity) becomes
essential to strengthen the cell wall when the β-1,3-
glucan synthesis is blocked.
A subgroup of mutants in genes related to cell wall
glucan metabolism, including fks1Δ and kre6Δ (β-1,3
and β-1,6-glucan synthesis), cwh41Δ (involved in β-1,6-
glucan assembly), gas1Δ and gas5Δ (β-1,3 glucanosyl-
transferases involved in β-1,3 glucan crosslinking), crh1Δ
(chitin-glucan crosslinking) and yps7Δ and mkc7Δ (GPI-
anchored aspartyl proteases necessary for cell wall
maintenance), showed reduced fitness to CR treatment.
Additionally strains lacking FKS1 and CWH41, or KRE6
and GAS1 were also hypersensitive to CAS or ZYM, re-
spectively, clearly indicating that β-1,3 glucan or a more
general glucan integrity network are essential to circum-
vent their effects. In contrast, deletion of FKS2, which
encodes for the alternative β-1,3 GS catalytic subunit,
was not identified in any of the screenings, in spite of
being transcriptionally induced under cell wall stress
conditions [13].
Genes necessary for the mannosylation of cell wall pro-
teins (PMT2 and MNN10), endocytosis and organization/
polarization of the actin cytoskeleton (END3 and SHE4)
were required to tolerate the damage generated by the three
compounds (Table 1). Highlighting the importance of cell
wall protein mannosylation for the integrity of the cell wall,
Mnn11, Ktr6, Kre2, Mnn2, and Hoc1 mannosyltransferases
were necessary for CR tolerance, while Och1, Cwh8 (both
also necessary to grow in presence of CAS), Mnn9, Pmt1,
Ecm33, Cwh36 and the aforementioned Hoc1 and Mnn11
Table 1 Mutant strains hypersensitive to Congo red, caspofungin, and zymolyase
ORF Gene Functional group Description
YML008Ca ERG6 carbohydrate and lipid metabolism Methyltransferase, converts zymosterol to fecosterol in the ergosterol
biosynthetic pathway
YBL058Wa SHP1 cell cycle UBX domain-containing protein, promotes cell cycle progression by positive
regulation of Glc7
YAL023C PMT2 cell wall and morphogenesis Protein O-mannosyltransferase of the ER membrane
YDR245W MNN10 cell wall and morphogenesis Subunit of a Golgi mannosyltransferase complex
YNL084Ca END3 cell wall and morphogenesis EH domain-containing protein involved in endocytosis and cell wall and
cytoskeletal organization
YOR035Ca SHE4 cell wall and morphogenesis Protein containing a UCS domain, binds to myosin motor domains to regulate
myosin function
YGL173C KEM1 protein and RNA metabolism 5'-3' exonuclease, component of cytoplasmic processing (P) bodies involved
in mRNA decay
YKL054Ca DEF1 protein and RNA metabolism RNAPII degradation factor, enables ubiquitination of RNAPII in an elongation complex
YJL080Ca SCP160 protein and RNA metabolism Essential RNA-binding G protein effector of mating response pathway
YDL006Wa PTC1 signaling pathways and response to stress 2C protein phosphatase involved in the dephosphorylation of multiple MAP kinases
YDR264C AKR1 signaling pathways and response to stress Palmitoyl transferase, acts as a negative regulator of pheromone response pathway
YDR477Wa SNF1 signaling pathways and response to stress AMP-activated serine/threonine kinase involved in derepression of
glucose-repressed genes
YHR030Ca SLT2 signaling pathways and response to stress Serine/threonine MAP kinase of the CWI pathway involved in maintenance
of cell wall integrity
YJL095Wa BCK1 signaling pathways and response to stress MAPKKK acting in CWI signaling pathway
YCR020W-B HTL1 transcription and chromatin remodeling Component of the RSC chromatin remodeling complex
YBL093C ROX3 transcription and chromatin remodeling Subunit of the RNA polymerase II mediator complex
YJL115W ASF1 transcription and chromatin remodeling Nucleosome assembly factor involved in chromatin assembly and disassembly
YOL148Ca SPT20 transcription and chromatin remodeling Subunit of the SAGA transcriptional regulatory complex
YEL044Wa IES6 transcription and chromatin remodeling Component of the INO80 chromatin remodeling complex
YJL204Ca RCY1 vesicular trafficking and transport F-box protein involved in recycling endocytosed proteins
YLL043W FPS1 vesicular trafficking and transport Aquaglyceroporin, plasma membrane channel, involved in efflux of glycerol
and xylitol
YLR138W NHA1 vesicular trafficking and transport Na+/H+ antiporter involved in sodium and potassium efflux through the
plasma membrane
YOR332Wa VMA4 vesicular trafficking and transport Subunit E of the V1 domain of the vacuolar H + −ATPase (V-ATPase)
YKL080Wa VMA5 vesicular trafficking and transport Subunit C of the V1 peripheral membrane domain of V-ATPase
YGR020Ca VMA7 vesicular trafficking and transport Subunit F of the V1 peripheral membrane domain of V-ATPase
YGR105W VMA21 vesicular trafficking and transport Integral membrane protein required for V-ATPase function
YHR060Wa VMA22 vesicular trafficking and transport Protein that is required for vacuolar H + −ATPase (V-ATPase) function
YKL119Ca VPH2 vesicular trafficking and transport Integral membrane protein required for V-ATPase function
Those gene deletions that have been associated to multidrug resistance (MDR) phenotype are labeled with superscripted “a”
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results are in agreement with previous observations
showing different levels of hierarchy in maintaining cell
wall homeostasis for mannosyltransferases, despite be-
ing highly redundant genes [9, 40, 41].
Interestingly, we found that mutants associated to micro-
tubule motor proteins and/or cytoskeletal organization
(CIN8, KAR3, NIP100, KIP1, CIK1, PAC11, TPM1, NUM1
or JNM1) were specifically sensitive to CR. Thisobservation points to a link between cell wall alter-
ations caused by CR and microtubule associated func-
tions, although some of these mutations could also
confer pleiotropic phenotypes.
Altogether, these results further support the existence
of specific compensatory mechanisms, affecting chitin
and glucan structure, when cell wall integrity is jeopar-
dized and reinforce the functional relationship between
cell wall maintenance and morphogenesis. Thus, genes
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and, mainly bud site selection were also broadly identi-
fied (Additional file 2).
MAPK signal transduction pathways and response to stress
During the last decade, a great amount of informa-
tion has been accumulated about the participation of
MAPK pathways, particularly the CWI pathway, in
the regulation of adaptive responses to cell wall dam-
age [7, 20]. Our results suggest that, although the
CWI pathway is the main pathway regulating cell
wall integrity, cooperation with other signal transduc-
tion pathways is also required. The architecture of
the different yeast MAPK pathways indicating those
elements identified in our genomic profiles is shown
in Fig. 2. In agreement with an essential role of the
CWI pathway, deletion of key elements of this path-
way like the MAPKKK Bck1 and the MAPK Slt2 in-
duced hypersensitivity to the three compounds (CR,
CAS and ZYM). Combined deletion of the two re-
dundant MAPKKs of this pathway (MKK1 and
MKK2) is necessary to cause sensitivity to CR and
ZYM [13, 14]. However, the single mutants were sen-
sitive to CAS, supporting the hypothesis that these
two proteins could play some non-redundant func-
tions [42]. Regarding the sensors of the CWI path-
way, deletion of WSC1/SLG1 and WCS3 caused
sensitivity to CR, while MID2 deletion caused CAS
sensitivity. Paradoxically, damage caused by CR is
mainly sensed by Mid2, while Wsc1 senses CAS
damage [36, 43]. These results might be explained in the
light of the blockade of the glucan-chitin compensatory
system, since Wsc1 directly regulates the GS Fks1 [44],
while Mid2 regulates chitin synthesis under stress condi-
tions [45]. In addition, Sac7 and Bem2, two Rho-type
GTPase-activating proteins (GAPs), are necessary to ad-
dress the damage caused by CR, and CAS, respectively,
supporting the idea that different Rho1 regulators elicit
specific outputs.
It is well known that fine regulation of MAPK
pathways is essential in eukaryotic physiology. In this
context, several mutants in genes encoding protein
phosphatases associated to MAPK signaling pathways
displayed altered growth fitness to the compounds
tested. This was the case of PTP2 (acts on Hog1,
Fus3 and Slt2) required to growth in the presence of
CR and ZYM, SIT4 (negative regulator of Pkc1)
whose absence renders cells hypersensitive to CR and
CAS, and PPS1 (which codes for a dual specificity
protein phosphatase not previously linked to MAPK
activity), required for CR tolerance. Moreover, the
growth of the ptc1Δ mutant strain in presence of all
three compounds was drastically inhibited, denoting
the relevance of this phosphatase under cell wall stressconditions. In agreement, the ptc1Δ slt2Δ double muta-
tion is synthetically lethal [46] and mutations of PTC1 re-
sults in the increased expression of genes that are also
induced by cell wall damage [47].
In addition to elements of the CWI pathway, all the
components of the Sho1 branch of the high-osmolarity
glycerol (HOG) pathway (Sho1, Opy2, Ste20, Ste50,
Ste11, Hog1 and Pbs2) were required to hinder the dam-
age caused by ZYM (Fig. 2 and Additional file 2) in
agreement with our previously reported cooperation
between the HOG and CWI pathways to respond
against cell wall stress caused by ZYM [14, 21]. Fur-
thermore, the absence of DIG1 (MAP kinase-
responsive inhibitor of the Ste12 transcription factor,
involved in the regulation of mating-specific genes
and the invasive growth pathway) and RHO4 (a small
GTPase likely involved in the establishment of cell
polarity) also caused sensitivity to ZYM, which might
be indicative of their participation in the dual regula-
tion by CWI and HOG pathways. How the signal
from the HOG pathway is transmitted to the CWI
route is still unknown, thus future characterization of
these mutants could be useful to address this issue.
Interestingly, the entire MAPK module of the invasive
growth pathway, STE11, STE7, and KSS1, in addition to
the CWI pathway, was required for CAS tolerance
(Fig. 2), pointing to a connection between CAS and in-
vasive growth.
Deletion of AKR1 and SNF1 also led to strains hyper-
sensitive to the three compounds (Table 1). AKR1 en-
codes a palmitoyl transferase, being palmitoylation a
reversible lipid modification that regulates membrane
tethering for key proteins in cell signaling [48, 49].
Palmitoylated proteins Yck1, Yck2 and Meh1, known
substrates of Akr1 were identified as hypersensitive in
some of our screenings, further supporting a crucial
role for the palmitoylation mediated by Akr1 for the
signaling network required to cope with cell wall stress.
The identification of SNF1 as a common target of the
three screenings could be related to a metabolic imbalance
caused by the reduced levels of glucose-6-phosphate in
the absence of this AMP-activated serine/threonine pro-
tein kinase, but it has also been recently suggested an in-
dependent role of this protein from carbohydrate
signaling in cell wall integrity [50].
Transcription and chromatin remodeling
The sensitivity to cell wall damage of a large number of
mutants deleted in genes related to transcription and
chromatin remodeling processes was somehow expected
because cellular adaptation to cell wall damage mainly
implies transcriptional regulation. In this regard, we found
genes encoding diverse elements of the transcriptional
machinery such as RNA polymerase II-associated proteins
Fig. 2 Yeast MAPK signaling pathways are associated to hypersensitivity to cell wall stress conditions. MAPK pathway elements whose deletion
causes hypersensitivity to CR, ZYM or CAS are labeled in red, blue or green, respectively
García et al. BMC Genomics  (2015) 16:683 Page 7 of 20or complexes (namely PAF, Mediator, Elongator and
CTDK-1 protein kinase) (see Additional file 2). For the
CAS screening the three subunits (CTK1, CTK2 and
CTK3) of the C-terminal domain kinase I (CTDK-I) wereidentified. The sensitivity of this set of mutants might
be related to the affected transcription of genes regu-
lated through the CWI pathway although additive ef-
fects of cell wall damage and other cellular functions
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be ruled out.
Moreover, we found a significant number of mutants
affected in chromatin remodeling and modification, for
which a critical role in establishment and maintenance
of transcriptional programs under stress conditions have
been established [51–53]. Chromatin structure is regu-
lated both by chromatin remodelers and factors that
covalently modify histones allowing transcription factor
accessibility at RNA Pol II promoters. Within the first
group, we identified mutants in elements of the SWI/
SNF complex, the SWR1 complex and the RSC complex
(Additional file 2). In agreement, we have recently char-
acterized the role of the SWI/SNF complex mediating
the chromatin remodeling necessary for adequate tran-
scriptional responses to cell wall stress [53].
Regarding histone modifications, we found that several
subunits of the histone acetyltransferase complex SAGA
were required to tolerate the damage generated by cell
wall stress, particularly by CR. In agreement, we have
also recently identified several subunits of this complex
in a transcriptional screening developed to identify mu-
tants defective in the induction of MLP1, a transcrip-
tional reporter of the CWI pathway [53]. This complex
seems to cooperate with the SWI/SNF complex for
chromatin remodeling of genes regulated through the
CWI pathway under cell wall stress conditions (Sanz
AB, García, R., Rodriguez-Peña, JM, Arroyo, J, unpub-
lished results). In parallel, another 12 mutants, mainly
CR and CAS hypersensitive, related to events of
histone acetylation (HAT) and deacetylation (HDAC),
like elements of the Hda1-associated complex (hda1Δ,
hda2Δ and hda3Δ strains), and elements of the Compass
complex, involved in histone H3 methylation were also
identified. All these elements play key regulatory mech-
anisms for both repression and activation of gene
expression.
Within this functional group, an aspect of interest was
to analyze in depth a group of 16 strains deleted in
different transcription factors. In theory, these factors
should positively regulate the expression of genes required
to grow in presence of the compounds under study. Some
of them regulate global responses to particular cellular
conditions such as Stp1 and Gln3, which participate in
aminoacid metabolism; Rox1, repressor of hypoxic genes;
Aft1, involved in iron uptake and utilization; or the
general transcriptional repressor complex Ssn6-Tup1. In
addition, we found altered growth fitness for mutants in
elements of the Ccr4-Not complex and the SBF complex.
In accordance with the observed sensitivity, loss of Ccr4
causes a decreased transcription of several genes involved
in cell wall biosynthesis [54] and the heterodimeric tran-
scriptional complex SBF, composed of Swi4 and Swi6, is
required for cell-cycle-regulated transcription of cell wallbiosynthetic genes and for transcriptional activation of
several genes through a non-catalytic mechanism medi-
ated by the MAPK Slt2 [55]. In fact, mutation of either
SWI4 or SWI6 results in sensitivity to calcofluor white
[56], a fluorochrome with a proposed mode of action on
the cell wall similar to CR. Strikingly, loss of Rlm1, a key
player in the transcriptional response to cell wall damage
[10, 13], only resulted in cells sensitive to CAS, and even
promoted resistance to CR (data not shown).
Five genes of this functional category were sensitive to
the three compounds (Table 1): ROX3 (encoding a sub-
unit of the RNA polymerase II mediator complex); ASF1
(involved chromatin assembly and disassembly); HTL1 (a
component of the RSC chromatin remodeling complex);
IES6 (component of the INO80 remodeling complex) and
SPT20 (encoding a subunit of the SAGA transcriptional
regulatory complex), supporting their importance for a
general cell wall adaptive response. However, although
elements of the different complexes within this functional
group were identified for the three compounds, a high
degree of specificity in the cellular response to each com-
pound was also found (Additional file 2), suggesting that
transcriptional regulation also requires particular subunits
of large protein complexes (subcomplexes), to deal with
different types of stresses on the cell wall.
Protein and RNA metabolism
As shown in Additional file 2, our chemical genomic
profiles revealed a large number of mutants in genes
related to RNA metabolism, translation (ribosomal pro-
teins), amino acid metabolism and protein modifications,
in agreement with a post-translational regulation of the
compensatory mechanism. It is noteworthy that 19 mu-
tants deleted in genes involved in ubiquitination-related
processes were sensitive, mainly to CR and/or CAS.
Ubiquitination contributes to the regulation of numer-
ous cellular processes, including cell cycle progression,
gene transcription and stress responses [57, 58]. Thus,
our data corroborate the importance of this type of
modification in the regulation of responses to cell wall
stress. Three genes, KEM1, DEF1 and SCP160, encoding
proteins involved in mRNA decay, ubiquitination of
RNA PolII and translation respectively, were identified
in the three screenings. The identification of Scp160 is
quite interesting. This RNA-binding protein is required
for efficient translation of a subset of mRNA via tRNA
recycling. A recent genome-wide survey of mRNAs
affected in translation as consequence of a SCP160 de-
letion included an enrichment in mRNAs encoding
cell wall proteins [59], although these mRNAs do not
correspond to those cell wall related genes induced in
the transcriptional CWI response. Our results open the
possibility that Scp160 plays an essential role in translation
of the pool of mRNAs over-produced under cell wall
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gard, it has been recently proposed that selective nu-
clear mRNA degradation controls the cell wall stress
response [60].
The GO functional group “tRNA wobble uridine modifi-
cation” was clearly enriched in strains hypersensitive to
CAS and CR (SIT4, NCS6, UBA4, URM1, KTI12, IKI3,
TRM9, ELP2, ELP3, ELP4). This is probably related to
their essential role in efficient translation of cell wall stress
mRNAs, as it has been recently demonstrated in Schizo-
saccharomyces pombe for oxidative stress [61].
Lipid metabolism
Mutants lacking genes associated to metabolism showed
a significant enrichment in the category of lipid metabol-
ism. These mutants were primarily affected in ergosterol
biosynthesis, such as erg2Δ, erg3Δ, erg4Δ, erg5Δ or erg6Δ,
and metabolism of sphingolipids (arv1Δ and isc1Δ). In
accordance with several screens that have identified erg6Δ
mutants with increased sensitivity to a broad range of
chemical compounds, in our hands this strain was hyper-
sensitive to the three compounds tested. It is well known
that the ergosterol pathway is closely connected with
sphingolipid metabolism, which has important structural
and signaling functions in fungal and animal cells [62].
Moreover, erg mutants are defective in pheromone signal-
ing and lipid rafts association of β-1,3 glucanosyltransfer-
ase Gas1 [63, 64]. The importance of sterols for yeast
survival is evidenced by the large number of antifungal
compounds affecting this route. Because the ergosterol
and sphingolipid pathways constitute complex systems, it
is difficult to predict which specific steps could provide
most effective drug targets and what would be the conse-
quences of the alteration of a particular enzymatic activity.
However, our data uncover alternative drug targets that
could be useful in combined therapies of cell wall-
interfering compounds and ergosterol biosynthesis inter-
fering drugs. Reinforcing this idea, it was recently reported
that in the arv1Δ mutant the CWI route is constitutively
activated indicating the presence of an altered cell wall [9].
Vesicular trafficking and transport
This is one of the largest functional groups identified in
our chemical genomic profiles. Encompasses a wide
range of cellular trafficking-related systems such as VPS
vacuolar sorting, endosomal sorting complexes (ESCRT),
SNARE complex and the V-type H+-ATPase, among
others. Six mutants in VMA genes (vma4Δ, vma5Δ,
vma7Δ, vma21Δ, vma22Δ and vph2Δ), corresponding
to different V-ATPase subunits, were highly sensitive
to CR, CAS and ZYM (Table 1), demonstrating the
importance of the V-ATPase activity under these
conditions. The vacuolar proton-translocating ATPase
(V-ATPase) is a multi-subunit complex divided in twosectors and couples energy from ATP hydrolysis (the
V1 sector) to the transport of protons against trans-
membrane gradients (the Vo sector). V-ATPase also
acidifies compartments of the biosynthetic pathway
such as the late Golgi apparatus and secretory vesicles.
The maintenance of these acidic compartments is crucial
for vesicle trafficking, in both endocytic and biosynthetic
pathways [65]. Indeed, it has been recently reported that
loss of V-ATPase activity leads to constant low-level
activation of the HOG pathway, and that the V-ATPase
itself is a salt-activated enzyme in yeast, suggesting
that V-ATPase acts in parallel with the HOG pathway
for salt detoxification [66]. The recent description of
ergosterol requirement for the V-ATPase function un-
covered a critical role for ion homeostasis downstream
of azole inhibition of ergosterol biosynthesis and sug-
gested that combining azole drugs and agents affecting
ion fluxes would have synergistic antifungal effect [67].
Bearing this in mind, we were prompted to test if inhibition
of the V-ATPase activity by fluconazole leads to a reduction
in fitness of yeast cells in the presence of cell wall stress
caused by CR, CAS or ZYM. To approach this, we mea-
sured cell growth of wild-type yeast cells treated with differ-
ent amounts of fluconazole ranging from 16 to 128 μg/ml
either in the absence or in the presence of sublethal con-
centrations of CR, CAS or ZYM (30 μg/ml, 15 ng/ml and
64 U/ml, respectively). As shown in Fig. 3, simultaneous
inhibition of the V-ATPase by fluconazole and cell wall
interference by CR, CAS or ZYM clearly leads to a syner-
gistic antifungal effect.
Genes of unknown function
One of the main objectives of a chemical-genomic
profiling is to contribute to the characterization of
genes with no function assigned. Mutants that show
similar chemical-genomic profiles are often involved
in a common or related biological process. In this
regard, 66 mutant strains deleted in genes encoding
proteins of unknown function or with only predicted
functions assigned were unraveled. 21 of these genes
were discarded because their loci overlapped in the
complementary strand with other genes identified in
our screening. 19 additional genes are labeled in SGD
as dubious open reading frame and partially overlap
with other verified genes. The remaining 26 genes
(Additional file 2) potentially include new genes
related to cell wall homeostasis. Included in this group
are: THP3 (probably involved in transcription elong-
ation), YEL043W and SLM6 (probably related to cyto-
skeleton), NNF2 (interacts with Rpb8 RNA PolII
subunit), SYH1 (possibly involved in COPII vesicle
formation) and YLR177W, which is a PSP1 paralog
(psp1Δ mutant strain was found to be hypersensitive
to CR), among others.
Fig. 3 Combination of fluconazole and CR, CAS or ZYM exhibits a
synergistic growth-inhibitory effect on yeast cells. Cell growth assays
were carried out in 96-well microtiter plates, preparing two-fold serial
dilutions of fluconazole (FZ) to give concentrations ranging from 128
to 16 μg/ml in a final volume of 150 μl of YEPD, either including a
constant concentration of CR (30 μg/ml, FZ + CR), CAS (15 ng/ml,
FZ + CAS) or ZYM (64 U/ml, FZ + ZYM) or not including the cell
wall stress (FZ). Cultures containing only CR, CAS or ZYM were also
included as growth control. Representative experiments for each
condition are shown
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profiles upon CR, CAS, and ZYM treatment
Chemogenomic and transcriptional profiles provide a
global perspective of the processes necessary to maintain
yeast cell wall homeostasis upon damage. Thus, we com-
pared the transcriptional profiles of yeasts growing in
the presence of CR, ZYM and CAS [13, 14, 68] with the
hypersensitivity profiles described here finding a lack ofcorrelation between gene expression and functional pro-
files, as previously described in a wide range of condi-
tions [17, 69]. This lack of correlation could be
consequence of gene functional redundancy and/or to
further levels of post-translational control. Interestingly,
some of the genes identified in both approaches corres-
pond to genes functionally very relevant for the cell
wall stress adaptive response like SLT2, the MAPK of
the CWI pathway, the phosphatase PTP2 that regulates
this pathway, FKS1 (encoding the β-1,3 GS), CRH1
(encoding the transglycosilase responsible for the
glucan-chitin crosslinking) and DFG5 (encoding a GPI-
anchored membrane protein required for cell wall bio-
genesis). The possibility that cell wall stress hypersensitivity
could be related to the role of the corresponding gene in
the development of adequate CWI transcriptional adaptive
responses led us to uncover those mutants within the set of
28 strains hypersensitive to all three conditions (CAS, ZYM
and CR) in which adaptive transcriptional response to the
three compounds would be blocked. In a previous report,
we developed a large-scale screening to identify genes
required for transcriptional activation under ZYM treat-
ment using a reporter system based on the expression levels
of theMLP1 gene [53].MLP1 shows low basal gene expres-
sion levels, but it is highly expressed under cell wall stress,
and this induction is largely dependent on Slt2 and Rlm1
[70]. 9 out of the 28 strains hypersensitive to all three
conditions were identified in that screening. Then, we mea-
sured MLP1 expression in these mutants after treatment
with CAS (15 ng/ml, 3 h), ZYM (0.8 U/ml, 3 h) and CR
(30 μg/ml, 3 h). As expected, deletion of SLT2 and BCK1
caused the blockade of MLP1 induction in the three condi-
tions. Interestingly, we found four additional mutants,
scp160Δ, def1Δ, shp1Δ and ies6Δ, showing a severe impair-
ment of reporter induction by the three stresses (Fig. 4).
These results suggest that reduced fitness of these mutants,
under situations which compromise cell wall integrity, is
due to a defective transcriptional adaptive response and
identify SCP160, DEF1, SHP1 and IES6 as functional ele-
ments required for regulation of gene expression through
the CWI pathway. Thus, chemical-genomic and genome-
wide gene expression profiling provide complementary
approaches to better understand the network of complex
processes involved in the maintenance of the cellular
homeostasis under cell wall threatening.
Identification of a common signature of cell wall
maintenance (CWM)-related genes
One of our goals was to identify a core of key genes
required for yeast survival under different cell wall
stresses. These genes could be considered potential can-
didates as antifungal targets, and the corresponding
mutant strains as biosensors to detect active molecules
on the fungal cell wall. As detailed above, comparison
Fig. 4 MLP1 induction by cell wall stress is reduced in some
mutants belonging to the CWM group. Expression of pMLP1-LacZ
was measured in wild-type (BY4741) and scp160Δ, def1Δ, sph1Δ,
ies6Δ mutants growing during 3 h at 30 °C either in the absence or
in the presence of CR (30 μg/ml), CAS (15 ng/ml) or ZYM (0.8 U/ml).
Relative β-galactosidase activity respect to the wild-type strain
(100 % of activity) for each condition is presented. Three independent
experiments were carried out to calculate means and standard
deviations
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28 genes whose deletion renders strains hypersensitive
to treatment with the three compounds tested (Table 1).
Since these compounds interfere directly with the cell wall
by different mechanisms, this set of genes would contain
essential common functions required to withstand cellFig. 5 Comparison of data from CR, CAS, ZYM and published cell integrity
identified in our screenings was compared to data from the following pub
killer toxins which bind to different cell wall receptors, ultimately forming l
derivative of chitin which eventually causes plasma membrane stress accom
stress, which have been related to defects in cell wall biogenesis or assemb
acidic conditions, for which a proper cell wall maintenance and architectur
low dye binding (ldb) phenotypes associated with altered mannoprotein-li
altered budding pattern [94] and morphological phenotypes [95]. A graphi
to the different conditions analyzed, and genes whose deletion cause a phen
analyzed are represented in the horizontal axis. Black indicates absence of hypwall damage independently of the nature of the damage.
Complementary, we have compared our complete set of
636 genes with data from a selected group of previously
published large-scale phenotypic screenings under con-
ditions that directly or indirectly compromise cell in-
tegrity (Fig. 5).
From this comparative analysis, we found that 75 % of
the mutants with reduced tolerance to CAS, ZYM or CR
showed altered fitness in at least one of the conditions
under comparison (data not shown). This analysis
allowed us to define a group of 18 genes common to
more than 60 % of the conditions examined (Fig. 5),
excluding the genes previously assigned to the group
of multidrug resistance genes. All these genes, except
STO1, ASC1 and VPS45, were also identified in at least
two of our screenings and three genes (MNN10, AKR1
and VMA21) were included in the core of strains
hypersensitive to CR, ZYM and CAS. Similarly to the
core of 28 genes whose deletion renders strains hyper-
sensitive to treatment with the three compounds
tested (Table 1), this group included functions primar-
ily related to cell wall biogenesis, transcription, pro-
tein and RNA metabolism and vesicular trafficking/
transport.
On the basis of these results, we propose to define a com-
mon set of 43 genes as “cell wall maintenance (CWM)”related phenotypic screenings. The complete gene set of 636 genes
lished large-scale phenotypic screenings: sensitivity against K1 and K2
ethal pores in the plasma membrane [27, 86]; chitosan, a deacetylated
panied by structural changes in the cell wall [87]; freeze-thaw or heat
ly [88, 89]; aluminum, the small glycopeptide antibiotic bleomycin or
e appears to play an important protective role [90–92]; detection of
nked oligosaccharides located in the outer layer of the cell wall [93];
cal representation of this comparison is shown. Vertical axis corresponds
otype of hypersensitivity (labelled in red) in at least eight of the conditions
ersensitivity phenotype
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fied as positive in our three screenings together with the
additional 15 genes identified by clustering with other
conditions related to cell integrity. As proof of its relevance
in the cell wall homeostasis, between 72–78 % of mutants
included in the CWM group exhibited medium or high
sensitivity levels (class 2 and 3) to each of the tested com-
pounds in comparison with the 53–58 % obtained when
the complete set of positive hits was considered (Table 2).
Sorbitol provides osmotic stabilization to mutants suffer-
ing from defects in the cell wall integrity and prevents cell
lysis caused by a weakened cell wall. Therefore, phenotyp-
ical remediation of temperature sensitivity by sorbitol has
been related to cell wall function deficiency [71, 72]. Based
on this, we evaluated if addition of sorbitol 0.8 M to the cell
culture was able to rescue the hypersensitivity phenotypes
of the 43 mutants included in the “CWM” signature
(Table 2 and Additional file 3). Addition of sorbitol resulted
in remediation of 62 %, 31 % and 23 % of the mutants
hypersensitive to CR, CAS and ZYM, respectively (Table 2).
These results support a direct osmotic stabilization of cell
wall integrity defects in these mutants. The highest percent-
age of remediation for CR phenotypes suggests a more
direct effect of this compound on cell wall integrity, having
apparently more impact on cellular osmotic stability. The
absence of remediation in the rest of mutants indicates that
osmotic support is not enough to revert their phenotypes,
probably because the nature of the damage prevents cell
growth independently of an osmotic stabilization or be-
cause in addition to the cell wall integrity, other cellular
functions, such as signal transduction or cytoskeleton asso-
ciated functions, are impaired in these mutants.
Caspofungin resistant strains: association with lipid
environment
Echinocandins are the most recent addition to the anti-
fungal arsenal and have rapidly become essential in the
treatment of fungal infections refractory to traditional
therapies. They are cyclic lipopeptide molecules that in-
hibit the β-1,3-GS activity resulting in the inability of the
fungus to build β-1,3-D-glucan chains. GS is composed
of at least two subunits; a putative catalytic subunit
(encoded by FKS1 and FKS2) and a regulatory subunit
encoded by RHO1 (for a review see [73–75]). Although
extensively studied, important gaps remain about the
echinocandins mechanism of action. CAS is one of the
clinically introduced echinocandins, for which genetic
screens of S. cerevisiae deletion libraries for resistant
mutants has been pursued as a method to identify cellu-
lar functions affected by this drug [28, 29, 76]. Consider-
ing the clinical significance of this resistance and the low
degree of overlaping genes identified in the previous
studies, we performed a screening to identify mutants
resistant to CAS using the same strategy utilized for theselection of hypersensitive mutants but in the presence
of 60, 90 and 120 ng/ml of the drug, corresponding to
1.5, 2.25 and 3-fold higher than the minimal inhibitory
concentration (MIC) (see Methods). 25 mutant strains
showed enhanced CAS resistance, including 13 genes
that had not been previously identified, thereby increas-
ing significantly the number of genes associated with
this phenotype (Table 3). One of the mutants identified
was wsc1Δ, deleted in one of the sensors of the CWI
pathway and defective in Rho1-dependent activation of
GS [44]. In the absence of Wsc1, the MAPK Slt2 is not
activated in the presence of CAS [43] and therefore the
transcriptional response to this drug is severely im-
paired [36].
An important group of hyper-resistant strains was af-
fected in genes functionally related to lipid metabolism,
including genes involved in sphingolipid biosynthesis like
CSG2, ELO2, ELO3, CKA2 and SUR1, sterol biosynthesis
(SAY1, ERG3 and NSG2), fatty acid synthesis (ETR1) and
translocation of phospholipids across the plasma mem-
brane (LEM3) [77]. Yeast cells lacking LEM3 have recently
been reported to exhibit resistance to the N-glycosylation
inhibitor tunicamycin in a screening to identify carriers in-
volved in drug uptake [78]. The yeast β-1,3 GS is inhibited
non-competitively by intermediates of the sphingolipid
biosynthesis, dihydrosphingosine (DHS) or phytosphingo-
sine (PHS), being in vivo PHS the primary GS inhibitor
[79]. Accumulation of PHS/DHS might repress the inter-
action between Fks1 and Rho1 or alternatively alter the
environment of lipid bilayer, causing inactivation of GS. In
Candida glabrata, membrane sphingolipids also modulate
echinocandin-Fks interaction, the accumulation of long
chain bases (LCBs) DHS or PHS conferring resistance to
CAS [76]. To evaluate the possible association between
GS activity and enhanced CAS resistance, we determined
in vitro the activity of this enzyme in the membrane frac-
tion of the 25 mutants identified in our screening. As a re-
sult, only three of them, wsc1Δ, elo2Δ and elo3Δ, showed
a significant decrease in the β-1,3-GS activity (Fig. 6 and
data not shown) compared to the wild type strain, but still
maintaining an in vivo GS activity enough for cell viability.
A decrease in the GS activity of the elo2Δ mutant strain,
affected in sphingolipid biosynthesis and resistant to echi-
nocandins, has been previously described [80]. Our data
show that Elo3 is also required for an adequate GS activ-
ity. However, mutants csg2Δ (Csg2 is required for manno-
sylation of inositol phosphorylceramide (IPC)), sur1Δ
(Sur1 encodes the Mannosylinositol phosphorylcera-
mide (MIPC) synthase catalytic subunit) and cka2Δ
(Cka2 is involved in phosphorylation of ceramide
synthase), although also involved in the synthesis of
complex sphingolipids, did show levels of GS activity
similar to that of the wild-type strain (Fig. 6). This ob-
servation opens the possibility that IPC accumulation
Table 2 Cell wall maintenance (CWM)-related genes
Hypersensitivity levels Sorbitol-remediable hypersensitivity
ORF Gene CR CAS ZYM CR CAS ZYM
YML008C ERG6 2 2 1 N N N
YBL058W SHP1 2 3 2 Y Y Y
YAL023C PMT2 3 1 2 Y Y Y
YDR245W MNN10 1 3 3 Y N N
YNL084C END3 3 2 1 N N Y
YOR035C SHE4 3 3 3 Y Y Y
YGL173C KEM1 1 1 1 N N N
YKL054C DEF1 3 2 3 Y N N
YJL080C SCP160 2 1 1 N N N
YDL006W PTC1 3 2 2 Y N N
YDR264C AKR1 1 2 3 N N N
YDR477W SNF1 2 2 2 N Y N
YHR030C SLT2 3 3 3 Y Y Y
YJL095W BCK1 3 2 3 Y Y Y
YCR020W-B HTL1 3 2 3 Y N N
YBL093C ROX3 2 2 3 N N N
YJL115W ASF1 3 2 1 Y N N
YOL148C SPT20 1 1 2 N N N
YEL044W IES6 1 1 1 N N N
YJL204C RCY1 3 2 1 Y N N
YLL043W FPS1 1 2 2 Y Y Y
YLR138W NHA1 2 3 3 Y Y Y
YOR332W VMA4 2 2 1 N N N
YKL080W VMA5 3 2 3 Y N N
YGR020C VMA7 2 2 2 Y N N
YGR105W VMA21 2 2 2 N N N
YHR060W VMA22 2 2 2 Y N N
YKL119C VPH2 3 2 1 Y N N
YOL072W THP1 1 1 ─ N N ─
YGR036C CAX4 ─ 2 2 ─ N N
YMR307W GAS1 2 ─ 3 Y ─ N
YEL027W VMA3 ─ 2 1 ─ N N
YDR364C CDC40 1 1 ─ Y Y ─
YMR116C ASC1 2 ─ ─ Y ─ ─
YLR342W FKS1 3 2 ─ Y Y ─
YLR182W SWI6 2 2 ─ Y Y ─
YPR139C LOA1 1 1 ─ N N ─
YGR262C BUD32 ─ 2 3 ─ N N
YJL062W LAS21 3 ─ 2 Y ─ N
YJL183W MNN11 3 ─ 2 Y ─ N
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Table 2 Cell wall maintenance (CWM)-related genes (Continued)
YLR262C YPT6 3 ─ 2 N ─ N
YMR125W STO1 1 ─ ─ N ─ ─
YGL095C VPS45 ─ ─ ─ ─ ─ ─
Low, medium and high levels of hypersensitivity are indicated as 1, 2, and 3, respectively. Cell growth similar to the wild-type strain is shown as "─". Sorbitol-remediable
and non-remediable phenotypes are denoted with "Y" and "N", respectively
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be associated to CAS interaction and resistance, but
without affecting directly GS activity. This is consist-
ent with the fact that mutations of Fks1 GS that confer
resistance to echinocandins, also present a GS activity
similar to that of the wild type GS [81–83]. Next, weTable 3 Genes whose deletion causes enhanced resistance to caspo
ORF Gene Functional group Description
YBR105C VID24 • CR carbohydrate metabolism GID Complex regulat
complex member Vid
YCL061C MCR1 cell cycle S-phase checkpoint p
YJL157C FAR1 cell cycle Inhibitor of Cdc28-Cln1
YOR008C SLG1 • cell wall Sensor-transducer of
cell wall integrity
YBR026C ETR1 lipid metabolism 2-enoyl thioester redu
YBR036C CSG2 • CR lipid metabolism ER membrane protein
(sphingolipids biosyn
YCR034W ELO2 • CR lipid metabolism Fatty acid elongase in
YGR263C SAY1 lipid metabolism Sterol deacetylase, co
YLR056W ERG3 • lipid metabolism C-5 sterol desaturase,
(ergosterol biosynthe
YLR372W ELO3 • CR lipid metabolism Elongase involved in
YNL156C NSG2 lipid metabolism Protein involved in re
YPL057C SUR1 • CR lipid metabolism Mannosylinositol phos
YPL118W MRP51 CR mitochondrial Mitochondrial ribosom
YBR048W RPS11B protein metabolism Protein component o
YBL075C SSA3 stress ATPase, member of t
and the response to
YNL080C EOS1 • stress Protein involved in N
YOR061W CKA2 • CR transcription Alpha' catalytic subun
growth and proliferat
YNL323W LEM3 • transport Protein of the plasma
the plasma membran
YBL029W unknown Non-essential protein
YBR071W unknown Protein of unknown f
YDR360W OPI7 unknown Dubious open readin
YEL025C unknown Putative protein of un
YOR024W • unknown Dubious open readin
YOR118W • CR unknown Protein of unknown f
YPR038W IRC16 unknown Dubious open readin
Those deletion mutants that have been previously reported to be resistant to caspo
respect to the wild-type strainwondered if CAS resistance correlates with resistance
to other cell wall injuries. We were unable to carry out
these assays with zymolyase due to the intrinsic resist-
ance of the wild-type strain to this compound (growth was
only partially reduced even in the presence of 500 U/ml).
To test resistance to Congo red, we employed the spotfungin
ory subunit involved in response to glucose through interactions with
28
rotein required for DNA replication
and Cdc28-Cln2 kinase complexes involved in cell cycle arrest for matin
the stress-activated CWI kinase pathway involved in maintenance of
ctase with a probable role in fatty acid synthesis
required for mannosylation of inositol phosphorylceramide
thesis)
volved in sphingolipid biosynthesis
mponent of the sterol acetylation/deacetylation cycle along with Atf2
catalyzes the introduction of a C-5(6) double bond into episterol
sis)
fatty acid and sphingolipid biosynthesis
gulation of sterol biosynthesis stabilizing Hmg2 protein
phorylceramide (MIPC) synthase catalytic subunit (sphingolipids biosynthesis)
al protein of the small subunit
f the small (40S) ribosomal subunit
he heat shock protein 70 (HSP70) family, involved in protein folding
stress
-glycosylation
it of casein kinase 2 (CK2) a Ser/Thr protein kinase with roles in cell
ion
membrane and ER involved in translocation of phospholipids across
e
of unknown function
unction, may be regulated by the cell cycle and/or cell wall stress




g frame, partially overlaps verified gene ERV2/YPR037C
fungin are labeled with a black dot. CR indicates resistance to Congo red
Fig. 6 Quantification of the β-1,3-glucan synthase (GS) activity of
mutants resistant to Caspofungin. Cell extracts from early log-phase
cultures in YEPD medium at 30 °C of the wild-type (BY4741) and the
25 CAS resistant mutant strains were obtained, and used for enzymatic
assays as described in Methods. It is shown the GS activity of the six
mutants related to sphingolipid biosynthesis. Bars represent the
percentage of GS specific activity in each mutant compared to that
of the wild-type strain (100 % of GS specific activity). Data are the
mean of three independent experiments. Error bars represent SD.
Statistical analysis was carried out with a two-tailed, unpaired,
Student’s t-test to analyze differences between the indicated
mutants and the wild-type strain: **P ≤ 0.01; ***P ≤ 0.001
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dye. This concentration severely impaired the growth of
the wild-type strain and allowed us to identify resistant
mutant strains. From the 25 strains tested, 8 (32 %)
manifested a resistance phenotype (Table 3). Interest-
ingly, the five strains involved in sphingolipid biosyn-
thesis described above were detected within this group,
reinforcing the notion of the key role of sphingolipids
in cell wall maintenance. These results are in agree-
ment with the hypothesis that sphingolipids regulate
stress resistance, since down-regulating sphingolipid
synthesis renders cells resistant to heat, oxidative and
acetic acid stresses [84].
Conclusions
The characterization of the molecular mechanisms re-
quired for cell wall maintenance, including those govern-
ing adaptation to cell wall stress, is absolutely necessary,
not only to understand the basis of relevant biological
processes like cell wall construction and morphogenesis,
but also for the discovery of new antifungal targets. This
work contributes significantly to these objectives by rely-
ing on a chemical-genomic profiling strategy to identify
functional relationships between specific genes and chem-
ical compounds that affect yeast cell wall integrity by
means of different mechanisms of action, namely CR,
CAS, and ZYM.
Functional analysis of the identified mutants shows that
fungal cells buffer the damage in specific components ofthe cell wall through multiple complementary mecha-
nisms. Indeed, mutants affected in glucan network and
organization of the cytoskeleton or chitin synthesis
were especially sensitive against the chitin-binding dye
CR and the β-1,3-GS inhibitor CAS, respectively
whereas strains affected in protein mannosylation
were hypersensitive to the three compounds but
mainly to ZYM, an enzymatic complex that affects the
entire cell wall. In addition to the cell wall, the most
important functions uncovered included signal trans-
duction, chromatin remodeling and transcription, RNA
metabolism, vesicular transport and ion homeostasis. Al-
though these functional groups were in common to the
three different compounds assayed, specific genes/proteins
were required to cope with distinct cell wall stresses, sug-
gesting a broad versatility of the cell wall stress response
network.
A limited but significant core of 28 deletion strains
displayed overlaping fitness profiles for the three com-
pounds, unraveling essential functions required to toler-
ate cell wall stress independently of the nature of the
damage. Comparison of our phenotypical profiles with
previous studies using conditions putatively affecting cell
integrity, uncovered an additional cluster of 15 deletion
strains, defining a common set of 43 genes named here
as a “cell wall maintenance (CWM)” gene signature.
Those functional groups within this signature included:
a) Cell wall and morphogenesis, including genes in-
volved in cell wall protein mannosylation and matur-
ation (MNN10, MNN11, PMT2, LAS21, CAX4), cell
wall remodeling (GAS1, FKS1) and cytoskeleton (END3,
SHE4); b) Transcription and chromatin remodeling,
including components of the RNA PolII Mediator, RSC,
SAGA, INO80, SWR1 and Swi6, a component of the
SBF (Swi4-Swi6) and MBF (Mbp1-Swi6) transcriptional
complexes; c) Signal transduction and stress response:
as expected, the MAPK Slt2 and the MAPKK Bck1 of
the CWI pathway were included in this group. Add-
itionally, the phosphatase Ptc1, the palmitoyl transfer-
ase Akr1 and the AMP-activated Ser-Thr kinase Snf1
seem to be very important for cell wall stress adapta-
tion; d) RNA metabolism, including the RNA binding
protein Scp160, required for translational efficiency of
codon-optimized mRNAs in yeast; e) Ergosterol biosyn-
thesis (ERG6) and f ) Vesicular trafficking and transport
(mainly those required for V-ATPase activity). This is
one of the largest functional group identified in our
chemical genomic profiles. It includes a wide range of
cellular trafficking-related systems such as VPS vacu-
olar sorting, endosomal sorting complexes (ESCRT),
SNARE complex and the V-type H + -ATPase. All these
genes included in the “cell wall maintenance (CWM)”
gene signature might be used as biomarkers of cell wall
stress in future genomic-fitness profiles.
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stresses were also uncovered. For CR, the CWI pathway
was the main route involved, whereas decreased tolerance
to ZYM was dependent on both the CWI and HOG
MAPK pathways. Intriguingly, for CAS, in addition to the
CWI pathway, the complete kinase module belonging to
the invasive growth MAPK pathway (Ste11, Ste7 and
Kss1) was also uncovered. This observation points out to
a possible connection between the CWI and the invasive
growth pathways, bearing in mind that the transcriptional
response to CAS is completely dependent on the CWI
sensor Wsc1 [36].
The search for mutants showing increased resistance
to CAS identified 25 genes associated to this phenotype,
including several genes involved in the synthesis of
sphingolipids and ergosterol. Interestingly, three of these
mutants, wsc1Δ, elo2Δ and elo3Δ, presented decreased
GS activity further confirming that specific lipid content
affects GS activity. In contrast, some of the mutations
identified affecting sphingolipids amount were associated
to CAS resistance without affecting GS activity. More-
over, deletion of genes involved in sphingolipid biosyn-
thesis also rendered cells resistant to CR, further
confirming a key role for sphingolipids in global cell wall
integrity maintenance under stress.
Taking into account the compensatory mechanisms
triggered against cell wall defects, the knowledge pro-
vided here might be useful for identification of potential
antifungal targets in a more efficient antifungal strategy
by combination of two drugs, one targeting the cell wall
and the other interfering with the adaptive mechanisms.
In this context, our cell wall-chemogenomic profiles
clearly point to the importance of the V-ATPase func-
tion for withstanding the cell wall damage caused by
different cell wall interfering-compounds. In agreement,
we found that simultaneous inhibition of the V-ATPase
by fluconazole and of cell wall biogenesis by cell wall
interfering-drugs leads to synergistic antifungal effects.Methods
Yeast strains and media
Experiments were performed with the full collection of
Saccharomyces cerevisiae strains (BY4741 background,
MATa; his3Δ-1; leu2Δ-0; met15Δ-0; ura3Δ-0) individu-
ally deleted in all of the ORFs identified in this organism
(4786) that were replaced by the Geneticin resistance
codifying KanMX4 module. This collection was provided
by Euroscarf (Germany). S. cerevisiae was grown on
YEPD medium (2 % glucose, 2 % peptone, 1 % yeast
extract). When required, sorbitol (PanReac-AppliChem,
Spain) 0.8 M or fluconazole (Fluka, Sigma-Aldrich,
USA) were added at the specified concentrations to the
culture media.Screening for yeast mutants hypersensitive to zymolyase
(ZYM)
The full collection of yeast mutant strains were grown in
100 μl of YEPD medium in 96-well microtiter plates for
24 h at 30 °C. Then, cultures were diluted preparing a
new set of plates containing 180 μl of fresh YEPD per
well plus 5 μl of the original cultures. Finally, plates con-
taining 100 μl of YEPD plus 30 U/ml of zymolyase 20 T
(ImmunO™, MP Biomedicals, USA) were inoculated with
5 μl of the aforementioned plates and incubated in a static
culture at 30 °C. After 24 h, growth was determined by
measuring absorbance at 595 nm (A595) in each well using
a microplate reader (Model 680, Bio-Rad, USA). Growth
inhibition by ZYM for each strain was calculated relative
to the A595 value of a wild-type strain handled in the same
conditions. Three categories of hypersensitivity to ZYM
were arbitrary defined consisting of those mutants with a
growth rate relative to the wild type strain in the presence
of the enzymatic complex about 50–26 % (class 1), 25–
11 % (class 2), and ≤ 10 % (class 3). Positive hits from this
chemical-genomic profile were confirmed by determin-
ation of the minimum inhibitory concentration (MIC) for
ZYM (see below).
Screening for yeast mutants hypersensitive to Congo
red (CR)
The collection of yeast mutant strains were grown over-
night in 96-well microtiter plates in 100 μl of YEDP
medium at 30 °C. Then, cultures were diluted preparing
a new set of plates containing 95 μl of YEPD per well
plus 5 μl of the original cultures. From these new plates,
three serial 1:10 dilutions were prepared in fresh YEPD
and 5 μl of each dilution was spotted with a 6 × 8 array
replica platter (Sigma-Aldrich, USA) onto solid YEPD
and YEPD plus 50 μg/ml of Congo red (Merck Millipore,
USA) plates. After 40, 70 and 100 h of incubation at
30 °C, the level of growth for each mutant strain was
recorded. Hypersensitivity to CR was determined com-
paring the growth on CR-containing plates respect to the
wild-type (BY4741) and the slt2Δ strains. The slt2Δ mu-
tant was selected since its hypersensitivity to cell wall
stress is well known [13]. Mutant strains hypersensitive
to CR were arbitrarily grouped in three categories taking
as reference the behavior of slt2Δ mutant grown at the
same conditions. Class 3 includes mutant strains more
sensitive to CR than slt2Δ; class 2 was assigned when the
sensitivity to CR was similar to slt2Δ; and class 1 com-
prises strains with reduced growth respect to the wt
strain but higher than slt2Δ.
Screening for yeast mutants hypersensitive and resistant
to caspofungin (CAS)
The complete collection of yeast mutant strains were
grown in 96-well microtiter plates in 100 μl of YEDP
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sitivity screening, 2 μl of these cultures were inoculated
in a new set of 96-well microtiter plates containing 98 μl
of YEPD and 98 μl of YEPD plus 10, 20 and 30 ng/ml of
caspofungin (provided by MSD Research Laboratories,
USA). YEPD containing 60, 90 and 120 ng/ml of CAS
was used to identify mutants resistant to this drug. After
46 h of static incubation at 30 °C, growth was deter-
mined by measuring the absorbance at 595 nm in each
well using a microplate reader (Model 680, Bio-Rad,
USA). The level of sensitivity of each mutant to each
concentration of CAS tested was calculated as the fol-
lowing ratio: absorbance in YEPD plus CAS/absorbance
in YEPD. A mutant strain was considered hypersensitive
to the drug when this ratio was ≤0.5 (growth decrease
≥50 %). Positive hits were confirmed performing a new
screening following the same strategy as described
above. Eventually, three categories of hypersensitivity to
CAS were defined: mutant strains hypersensitive at 10,
20 and 30 ng/ml of CAS (class 3), hypersensitive at 20
and 30 ng/ml (class 2), and hypersensitive only at 30 ng/
ml (class 1). On the other hand, a mutant strain was
considered resistant if the ratio (absorbance in YEPD
plus caspofungin)/(absorbance in YEPD), for the
three concentrations tested (60, 90 and 120 ng/ml) was
higher than 1.5 (growth increase ≥50 %).
Minimal inhibitory concentration (MIC) assays
ZYM, CR and CAS sensitivity assays were performed in
96-well microtiter plates, preparing two-fold serial dilu-
tions of zymolyase 20 T, Congo red and caspofungin to
give concentrations ranging from 125 to 0.25 U/ml,
1920 to 1.9 μg/ml and 1 to 0.001 μg/ml respectively, in a
final volume of 150 μl of YEPD. Each well was inocu-
lated with approximately 104 cells from an exponentially
growing culture. Plates were incubated at 30 °C and cell
growth was determined after 24 and 48 h by measuring
the absorbance at 595 nm using a microplate reader.
Sorbitol-remediable hypersensitivity assays were carried
out in the same way but in presence of sorbitol 0.8 M.
Cell growth remediation was considered when the MIC
was increased at least in one order of magnitude in the
presence of the osmotic support.
Hypersensitivity assays to fluconazol and cell
wall-interfering compounds
The assays were performed in a final volume of 150 μl
of YEPD in 96-well microtiter plates. Cell growth of
wild-type yeast cells, treated with different amounts of
fluconazole (ranging from 16 to 128 μg/ml) either in the
absence or in the presence of sublethal concentrations of
CR, CAS or ZYM (30 μg/ml, 15 ng/ml and 64 U/ml, re-
spectively), was determined after 24 h of incubation at
30 °C by measuring the absorbance at 595 nm.β-galactosidase assays
β-galactosidase assays were performed using crude cellular
extracts from exponentially growing yeast cells transformed
with the centromeric plasmid pMLP1-LacZ (promoter of
MLP1 fused to LacZ) as previously described [14].
Enzyme preparation and in vitro β-1,3-Glucan synthase
assay
Cell extracts and GS assays were performed essentially
as described previously [85]. Membrane enzyme extracts
were obtained from early log phase cells grown in YEPD
medium at 30 °C. GS assay mixture contained 5 mM
UDP-D-[14C]glucose (4 × 104 cpm/200 nmoles), 150 μM
GTPγS and membrane enzyme (20-40 μg of protein) in
a total volume of 40 μl. All GS assays were carried out in
duplicate and data for each strain were calculated from at
least three independent cell cultures. Statistical data ana-
lysis were done using the GraphPad V5 software.
Data analysis
Genes were assigned to functional categories using the
yeast Gene Ontology (GO) tool “GO Slim Mapper” and
further manually refined according to annotations of the
BIOBASE Knowledge Library Proteome and the Saccha-
romyces Genome Database (SGD). Statistically signifi-
cant functional groups, appearing in our lists at a
frequency greater than it would be expected by chance,
were obtained by means of Gene Ontology (GO) tool
“GO Term Finder” (version 0.83) using default settings at
the SGD link with GO category “Process”, p-value ≤ 0.01
and False Discovery rate (FDR) option. The Heat map
shown in Fig. 5 was obtained using the Multiexperiment
Viewer (MeV 4.9) software.
Deposition of data
Not applicable
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